SCHEMBL13780392

SCHEMBL13780392

CO[C@@H](Cc1ccc(OCC(C)c2sc(-c3ccc(C(F)(F)F)cc3)cc2C)cc1)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 15/20 0.46
PPARG P37231 14/20 0.46
PPARD Q03181 9/20 0.46
PTPN1 P18031 2/20 0.41
ADAMTS4 O75173 1/20 0.40
MMP13 P45452 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3952370 1.00 PPARA (0.46) PPARAPPARGPPARDPTPN1ADAMTS4
SCHEMBL5850587 0.81 PPARA (0.49) PPARAPPARGPPARDPTPN1
SCHEMBL3959780 0.79 PPARA (0.43) PPARAPPARGPPARD
SCHEMBL13780393 0.79 PPARA (0.43) PPARAPPARGPPARD
SCHEMBL3956363 0.79 PPARD (0.58) PPARAPPARGPPARD
SCHEMBL2067931 0.79 PPARD (0.58) PPARAPPARGPPARD
SCHEMBL3959758 0.79 PPARD (0.43) PPARAPPARGPPARD
SCHEMBL5850970 0.77 PTPN1 (0.58) PPARAPPARGPPARDPTPN1
SCHEMBL3957383 0.76 PPARD (0.48) PPARAPPARGPPARD
SCHEMBL13780399 0.76 PPARD (0.48) PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176863-A1 THIOPHENE DERIVATIVE PPAR MODULATORS MANTLO NATHAN BRYAN 2009-07-09 US disclosed
US-20090176863-A1 THIOPHENE DERIVATIVE PPAR MODULATORS MANTLO NATHAN BRYAN 2009-07-09 US disclosed
US-7504433-B2 Thiophene derivative PPAR modulators ELI LILLY AND COMPANY (US) 2009-03-17 US disclosed
US-7504433-B2 Thiophene derivative PPAR modulators ELI LILLY AND COMPANY (US) 2009-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176863-A1 THIOPHENE DERIVATIVE PPAR MODULATORS PPARA, PPARG, PPARD PPARA 1/4885PPARG 2/4885PPARD 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.